Quick Answer
REPLIGEN CORP reported Research And Development Expense of $54.18 million for the year ending 2025.
- REPLIGEN CORP showed an increase of +25.4% in Research And Development Expense from 2024 to 2025.
- This data is from REPLIGEN CORP's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2013: $1.42 million | Q1 2014: $1.20 million | Q2 2014: $1.43 million | Q3 2014: $1.65 million | Q4 2014: $1.33 million | Q1 2015: $1.57 million | Q2 2015: $1.25 million | Q3 2015: $1.49 million | Q4 2015: $1.43 million | Q1 2016: $1.54 million | Q2 2016: $1.89 million | Q3 2016: $1.89 million | Q4 2016: $2.04 million | Q1 2017: $1.74 million | Q2 2017: $1.86 million | Q3 2017: $2.00 million | Q4 2017: $3.07 million | Q1 2018: $3.29 million | Q2 2018: $5.78 million | Q3 2018: $3.60 million | Q1 2019: $3.62 million | Q2 2019: $5.23 million | Q3 2019: $5.43 million | Q1 2020: $4.70 million | Q2 2020: $4.34 million | Q3 2020: $4.42 million | Q1 2021: $7.61 million | Q2 2021: $8.39 million | Q3 2021: $9.15 million | Q1 2022: $12.16 million | Q2 2022: $10.44 million | Q3 2022: $10.23 million | Q1 2023: $12.15 million | Q2 2023: $9.71 million | Q3 2023: $10.58 million | Q1 2024: $11.24 million | Q2 2024: $10.58 million | Q3 2024: $9.71 million | Q1 2025: $12.92 million | Q2 2025: $13.96 million | Q3 2025: $14.18 million.
- Over the full 16 years of available data (2010 to 2025), REPLIGEN CORP's Research And Development Expense has grown by 282.6%.
- Historical annual values: Fiscal year 2025: $54.18 million | Fiscal year 2024: $43.20 million | Fiscal year 2023: $42.72 million | Fiscal year 2022: $43.94 million | Fiscal year 2021: $34.27 million | Fiscal year 2020: $20.18 million | Fiscal year 2019: $19.45 million | Fiscal year 2018: $15.82 million | Fiscal year 2017: $8.67 million | Fiscal year 2016: $7.36 million | Fiscal year 2015: $5.74 million | Fiscal year 2014: $5.61 million | Fiscal year 2013: $7.34 million | Fiscal year 2012: $10.49 million | Fiscal year 2011: $12.53 million | Fiscal year 2010: $14.16 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: